Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

Media coverage

• Title	Icahn School of Medicine at Mount Sinai Listed a New Clinical Trial to Study Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
  Media name/outlet	India Pharma News
  Country/Territory	India
  Date	27/10/21
  Persons	Amy Tiersten